BU
BNTX icon

BBVA USA’s BioNTech BNTX Stock Holding History

BBVA USA’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$375K Buy
+1,374
New +$437K 0.02% 366

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

BBVA USA's BNTX Position: Q3 2021 in Review

BBVA USA opened a new position in BioNTech (BNTX) in Q3 2021: 1,374 shares worth $375K. The stake represents 0.02% of the portfolio and ranks #366 among its holdings.

335 funds tracked by Wall St. Rank hold BNTX as of Q3 2021.

  • BBVA USA held 1,374 shares of BioNTech worth $375K as of Q3 2021.
  • BioNTech was a new BBVA USA position in Q3 2021.
  • BioNTech made up 0.02% of BBVA USA's portfolio in Q3 2021, its #366 holding.
  • 335 funds tracked by Wall St. Rank held BioNTech as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.